Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden
· Delayed Price · Currency is SEK 1.325
-0.015 (-1.12%)
Apr 29, 2026, 1:39 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 40.73 million as of April 29, 2026. Its market cap has decreased by -49.12% in one year.
Market Cap
40.73M
Enterprise Value
30.66M
Revenue
32.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.33
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 40.73M, a decrease of -83.44%. That is a compound annual growth rate of -34.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 40.73M | 16.52% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enorama Pharma AB | 19.77M |
| Gabather AB | 19.17M |
| Vivesto AB | 89.68M |
| Klaria Pharma Holding AB (publ.) | 233.43M |
| Cinclus Pharma Holding AB | 563.11M |
| Moberg Pharma AB | 564.01M |
| Nanexa AB | 623.78M |
| Enzymatica AB | 648.10M |